CAS: 2041073-22-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
GNF4877 REF: AN-AG01N18OCAS: 2041073-22-5 | 98% | 268,00 €~495,00 € | Mar 07 May 24 | |
GNF4877 REF: TM-T11447CAS: 2041073-22-5 | 99.11% | 191,00 €~2.756,00 € | Mar 14 May 24 | |
GNF4877 REF: 3D-RGD07322CAS: 2041073-22-5 | Min. 95% | A consultar | Mar 18 Jun 24 |
Ref: AN-AG01N18O
1mg | 268,00 € | |
25mg | 323,00 € | |
50mg | 495,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Mayo de 2024
GNF4877
CAS:2041073-22-5
GNF4877 is a potent DYRK1A and GSK3β inhibitor (IC50s: 6 nM and 16 nM). It …
Fórmula:
C25H27FN6O4
Pureza:
99.11%
Forma y color:
Solid
Peso molecular:
494.52
Ref: TM-T11447
1mg | 191,00 € | |
5mg | 537,00 € | |
10mg | 848,00 € | |
25mg | 1.607,00 € | |
50mg | 2.756,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Mayo de 2024
GNF4877
CAS:2041073-22-5
GNF4877 is an oral medication that has been shown to enhance the ability of insulin-producing …
Fórmula:
C25H27FN6O4
Pureza:
Min. 95%
Peso molecular:
494.5 g/mol
Ref: 3D-RGD07322
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Junio de 2024